Key facts
- This page summarizes Joey A. Jacobs's Form 4 filing for CUMBERLAND PHARMACEUTICALS INC (CPIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Mar 2023, 17:28.
Joey A. Jacobs - 14 Jan 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)
- Reporting relationship
- Director
- Issuer ticker
- CPIX
- Reported as of
- 14 Jan 2023
- Net transaction value
- -$13,750
- SEC form
- 4
- Accepted by SEC
- 21 Mar 2023, 17:28:43 UTC
- Prior SEC filing
- 29 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- Joey A. Jacobs by /s/ John Hamm as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joey A. Jacobs filed Form 4 for CUMBERLAND PHARMACEUTICALS INC (CPIX) on 21 Mar 2023.
Change
- Previous filing in this sequence was filed on 29 Apr 2022.
- Current net transaction value: -$13,750.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CPIX
transaction
Common Stock
Other
- Transaction value
- $13,750
- Shares
- -5,000
- Change %
- -4.8%
- Price
- $2.75
- Shares after
- 98,415
- Date
- 14 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Joey A. Jacobs is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
Mr. Jacobs passed away January 14, 2023. All unvested equity awards forfeited upon death.